State of Alaska Department of Revenue’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-56,129
Closed -$4.77M 1645
2019
Q4
$4.77M Sell
56,129
-782
-1% -$52.1K 0.06% 395
2019
Q3
$2.85M Buy
56,911
+33,150
+140% +$1.32M 0.04% 460
2019
Q2
$866K Buy
23,761
+1,606
+7% +$52.4K 0.01% 808
2019
Q1
$619K Buy
22,155
+135
+0.6% +$3.18K 0.01% 943
2018
Q4
$421K Buy
22,020
+681
+3% +$15.8K 0.01% 1068
2018
Q3
$638K Buy
21,339
+160
+0.8% +$6.03K 0.01% 957
2018
Q2
$777K Buy
21,179
+360
+2% +$11.7K 0.01% 811
2018
Q1
$685K Buy
20,819
+8,090
+64% +$253K 0.01% 801
2017
Q4
$348K Buy
12,729
+100
+0.8% +$3.08K 0.01% 964
2017
Q3
$467K Sell
12,629
-1,620
-11% -$59.7K 0.02% 714
2017
Q2
$541K Buy
14,249
+6,339
+80% +$282K 0.04% 383
2017
Q1
$386K Buy
7,910
+380
+5% +$17.3K 0.03% 427
2016
Q4
$255K Buy
+7,530
New +$267K 0.02% 373

Other funds holding MDCO

State of Alaska Department of Revenue's MDCO Position: Q1 2020 in Review

State of Alaska Department of Revenue sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 56,129 shares — an estimated $4.77M sold.

State of Alaska Department of Revenue first reported a position in MDCO in Q4 2016 and held it in 13 quarters. The position peaked at $4.77M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • State of Alaska Department of Revenue reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 56,129 Medicines Co shares in Q1 2020, an estimated $4.77M.
  • State of Alaska Department of Revenue first reported a position in Medicines Co in Q4 2016 and held it in 13 quarters.
  • State of Alaska Department of Revenue's Medicines Co position peaked at $4.77M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2020, filed 6 Apr 2020.